INFORACIÓN ACADÉMICA Y ADMISIONES

Credits - 70 / European ECTS credits

Pre-selection process: Open

Inscriptions: from October 2019 to August 2020

Master Program – October 2020 to June 2021.

Full Time - Monday to Thursday from 18:00h. to 21:00h.

Language - English

Limited Places

OBJETIVOS DEL MÁSTER

The objective of the program is to understand the relationship and different agreements negotiation processes between biotechnology-based companies and pharmaceutical companies in new compound acquisitions. The main skills and topics are related with international business development, portfolio increase, new valuation compounds, deal terms and conditions, milestones and royalties, and the negotiation process.

DESARROLLO PROFESIONAL

The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers. 

PROGRAMA ACADÉMICO

I. Global Ecosystem in Drug Discovery

II. Scientific and Regulatory Developemt

III. Profesional and Personal Leadership

IV. Portfolio Management

V. Global Marketing

VI. Master's Thesis - Licensing Agreement and Acquisition

Ver el programa académico aquí

TITULACIÓN DEL MÁSTER

Los estudiantes que aprueben el programa recibirán una doble titulación de la Universidad de Barcelona y el Instituto Empresarial de Biotecnologia en Master in Business Administration in LifeScience con especialidad en International Business Development.

                    


 

Solicitud de información